Is Chi Sheng Pharma Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Chi Sheng Pharma Biotech pays dividends. Last time was Friday 20th of September 2024 where the investors holding the stock on Friday 23rd of August 2024 were paid TWD1 per share. Over the last 17 times between 2008 and 2024, Chi Sheng Pharma Biotech has paid TWD11.1346 with an average of TWD0.65 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Chi Sheng Pharma Biotech 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD25.50, you would have made a profit of TWD1.700 per share or 6.67%
Yes, the average daily trading liquidity for Chi Sheng Pharma Biotech is TWD92 000 thousand. You should therefore be able to get in and out of your positions relatively fast.
Chi Sheng Pharma Biotech has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.82, the company's ability to pay off the debt is good. Chi Sheng Pharma Biotech has a good net profit margin of 6.47% and should have high tolerances against inflation.
We have calculated the inflation risk for Chi Sheng Pharma Biotech to be low [0.25 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.